Diabetes Company ViCentra Appoints Frans Cromme As CEO
ViCentra, which developed the Kaleido insulin pump, has appointed Frans Cromme as its new CEO.
You may also be interested in...
On this week’s podcast the commercial team discuss strategies medtech companies can take to recover from the impact of COVID-19, and a new $100m Pandemic Innovation Fund launched by Israeli investment firm OurCrowd.
MeMed has received CE Marking for its diagnostic test MeMed BV and point-of-need platform MeMed Key, which uses the human immune system to distinguish between bacterial and viral infections to prevent antibiotic overuse.
Medtronic's revenue for the fourth quarter of fiscal 2020 was down 25% year-year-over due to the COVID-19 pandemic. The hardest-hit segment was restorative therapies, which reported a 33% year-over-year decline in the quarter due to the drop off in deferrable procedures and capital purchases. For the full fiscal year, Medtronic's revenue was down 4.2% to $28.9bn.